Contact us

EBR, the Electronic Batch Record that eliminates quality rework

Every Head of Quality in the pharmaceutical industry has experienced this scenario. A batch is ready, production is halted, and an entire team is reviewing a paper batch log page by page, hunting for erasures, blank fields, or out-of-order signatures. This is called review by exception, but without any exceptions, because on paper everything becomes an exception.

EBR, short for Electronic Batch Record, exists to put an end to this scene.

What is EBR in practice?

EBR stands for Electronic Batch Record. Instead of the operator filling out printed forms during production, the system manages each step of the process, validates in real time whether the parameters are within the approved range, blocks further processing when something deviates from the specifications, and delivers a batch that is truly exception-reviewable at the end.

The key difference lies here. On paper, Quality reviews after the fact. In EBR, the system prevents deviation beforehand.

This changes the role of the Head of Quality. They cease to be the final filter that finds the error and become the one who designs the rules that prevent the error.

Why does this matter for compliance with ANVISA and FDA?

Brazilian Regulatory Standards RDC 658 and RDC 301, in addition to GMP and GAMP guidelines, require complete traceability, data integrity, and a reliable audit trail. A paper notebook depends on human discipline to meet these requirements. A well-implemented EBR (Environmental, Business, and Research) system achieves this by design.

During an inspection, the difference becomes apparent quickly. Finding a specific batch from last year, with all deviations documented and all electronic signatures traced, takes minutes in an electronic system and can take days in a physical file.

What changes in the team's day-to-day routine?

Three concrete benefits become apparent within the first few weeks of use.

Batch release time decreases because the review is no longer page-by-page and focuses only on actual deviations. Data quality improves because the system prevents blank fields, out-of-range values, and incorrect step sequences. And the Quality team gains time back for investigation and continuous improvement, instead of hunting for data entry errors.

None of these gains depend on increasing staff. It depends on removing the work that should never have been manual.

How does Oran+ solve this?

The Oran+ EBR module was developed within the Brazilian regulatory framework and already operates in Canada, with native compliance to ANVISA, FDA, GMP, and GAMP from the outset, not as an adaptation.

It connects to the platform's own weighing, OEE, and workflow modules, meaning that the weighing data that opens the batch is the same data that closes the electronic record, eliminating double entry and the risk of discrepancies between systems.

Pharmaceutical companies like Unither, Blanver, Airela, Cimed, Cristália, Galderma, Halexistar, and Ourofino already operate this logic in real-world production in Brazil, under the same legislation that governs their operations. This is rare. Most global competitors enter the country with a case study from their American or European parent company, translated, without any Brazilian plant behind them.

The first step before switching systems

Before making any purchase decision, it's worth mapping out where the stock still poses a risk to your operation today. Generally, three points emerge: the batch release time, the fill deviation rate, and the audit response time.

Anyone who can measure these three numbers already knows exactly the size of the gain that a well-implemented EBR brings. Always one step ahead in a competitive market. Want to know more? Talk to us.